Ramalingam Bethunaickan
Overview
    Explore the profile of Ramalingam Bethunaickan including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              45
            
            
              Citations
              1044
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Nancy Pandiarajan A, Kumar N, Moideen K, Thiruvengadam K, Hissar S, Sivakumar S, et al.
  
  
    Pathogens
    . 2025 Feb;
          14(2).
    
    PMID: 40005523
  
  
          Tuberculosis (TB) treatment monitoring is an essential tool for effective TB treatment management. Identifying parameters that predict adverse TB treatment outcomes could significantly improve clinical management. The association of hematological...
      
2.
        
    
    Gunasekaran H, Ranganathan U, Bethunaickan R
  
  
    Front Immunol
    . 2025 Feb;
          16:1538127.
    
    PMID: 39981231
  
  
          Infection with  (Mtb) triggers an autoimmune-like response in the host leading to further complications. One of the major concerns in eliminating Tuberculosis (TB) is identifying individuals with Latent Tuberculosis Infection...
      
3.
        
    
    Vanamudhu A, Devi Arumugam R, Nancy A, Selvaraj N, Moiden K, Hissar S, et al.
  
  
    Viruses
    . 2024 Aug;
          16(8).
    
    PMID: 39205152
  
  
          A natural infection or a vaccination can initially prime the immune system to form immunological memory. The immunity engendered by vaccination against COVID-19 versus natural infection with SARS-CoV-2 has not...
      
4.
        
    
    Nancy Pandiarajan A, Kumar N, Selvaraj N, Ahamed S, Viswanathan V, Thiruvengadam K, et al.
  
  
    Front Immunol
    . 2024 Jun;
          15:1392256.
    
    PMID: 38887283
  
  
          Introduction: The assessment of tuberculosis (TB) treatment outcomes predominantly relies on sputum culture conversion status. To enhance treatment management, it is crucial to identify non-sputum-based biomarkers that can predict unfavorable...
      
5.
        
    
    Murugesan H, Sampath P, A V, R S, Veerasamy A, Ranganathan U, et al.
  
  
    Gene
    . 2024 Jun;
          927:148679.
    
    PMID: 38876405
  
  
          Background And Objectives: Genetic factors are reported to be connected with tuberculosis (TB) infection. Studies have shown that genetic variations in genes involved in the vitamin D pathway influence the...
      
6.
        
    
    Gunasekaran H, Sampath P, Thiruvengadam K, Malaisamy M, Ramasamy R, Ranganathan U, et al.
  
  
    BMC Infect Dis
    . 2024 Apr;
          24(1):402.
    
    PMID: 38622570
  
  
          Background: Tuberculosis (TB) ranks as the second leading cause of death globally among all infectious diseases. This problem is likely due to the lack of biomarkers to differentiate the heterogeneous...
      
7.
        
    
    Sampath P, Moorthy M, Menon A, Madhav L, Janaki A, Dhanapal M, et al.
  
  
    Front Immunol
    . 2023 Jul;
          14:1197805.
    
    PMID: 37457712
  
  
          Background: Monocyte miRNAs govern both protective and pathological responses during tuberculosis (TB) through their differential expression and emerged as potent targets for biomarker discovery and host-directed therapeutics. Thus, this study...
      
8.
        
    
    Moideen K, Nathella P, Madabushi S, Renji R, Srinivasan P, Ahamed S, et al.
  
  
    Cytokine
    . 2023 Jun;
          168:156238.
    
    PMID: 37276815
  
  
          Background: Tuberculosis (TB), a life-threatening immune challenging disease to the global human community has to be diagnosed earlier and eliminated in the upcoming era. Vitamin D, a fat-soluble micronutrient, mainly...
      
9.
        
    
    Sampath P, Rajamanickam A, Thiruvengadam K, Natarajan A, Hissar S, Dhanapal M, et al.
  
  
    Sci Rep
    . 2023 May;
          13(1):7404.
    
    PMID: 37149713
  
  
          Tuberculosis (TB) diagnosis still remains to be a challenge with the currently used immune based diagnostic methods particularly Interferon Gamma Release Assay due to the sensitivity issues and their inability...
      
10.
        
    
    Sampath P, Rajamanickam A, Thiruvengadam K, Natarajan A, Hissar S, Dhanapal M, et al.
  
  
    Sci Rep
    . 2023 Jan;
          13(1):785.
    
    PMID: 36646786
  
  
          Tuberculosis (TB) elimination is possible with the discovery of accurate biomarkers that define the stages of infection. Drug-resistant TB impair the current treatment strategies and worsen the unfavourable outcomes. The...